INDIANAPOLIS, — Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has approved a new, more efficient workflow process for the cobas HPV Test, allowing sample processing from the primary sample collection vial after it has been used for cytology (Pap) testing. This development allows labs to load […]
SEATTLE, Wash. – NanoString Technologies, Inc., a provider of life science tools for translational research and molecular diagnostic products, today announced the pricing of its initial public offering of 5.4 million shares of common stock at a price to the public of $10.00 per share. In addition, the Company has granted the underwriters a 30-day […]
IRVINE, Calif.,– CombiMatrix Corporation (Nasdaq:CBMX), a molecular diagnostics company performing DNA-based testing services for developmental disorders and cancer diagnostics, today announced that its chromosomal microarray analysis (CMA) test for miscarriage analysis has received conditional approval from the New York State’s Department of Health for testing on patient samples from the state. With nearly 20 million […]
TETEROW, GERMANY, — Miltenyi Biotec GmbH today announced that the German medical regulatory authorities, the Arzneimittelüberwachungsbehörde (AMÜSt) of Mecklenburg-Vorpommern and the Paul-Ehrlich-Institut (PEI), have granted a license for the manufacture of the clinical lead candidate, MB101, at its GMP facility in Teterow, Germany. MB101 is a proprietary humanized, monoclonal antibody directed against an undisclosed target […]
SAN JOSE, Calif. – Thermo Fisher Scientific Inc., the world leader in serving science, and the Newman-Lakka Institute for Personalized Cancer Care at Floating Hospital for Children at Tufts Medical Center, announced an intended collaboration for research and development of new methods to detect and track circulating biomarkers in blood. The collaboration will focus on […]
SALT LAKE CITY – BioFire Diagnostics, Inc., announced today the FDA clearance of its FilmArray Blood Culture Identification (BCID) Panel. To date, the 27-target panel is the most comprehensive test to be approved by the FDA. The FilmArray BCID Panel provides results from positive blood cultures, and can identify more than 100 blood pathogens known […]
BOTHELL, Wash., — BioLife Solutions, Inc. (OTCQB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues, and contract aseptic media manufacturer, and HemaCare Corporation, (OTCPK:HEMA), a leading supplier of blood derived cells and components for research and clinical applications, today announced a strategic […]
Murrieta, CA, –The CHU de Québec, one of the most important healthcare institutions in the province of Québec and one of the biggest in Canada, and COPAN Diagnostics, Inc., announced today the full installation of WASPLab, the latest generation of full laboratory automation and digital microbiology system in Hôpital de l’Enfant-Jésus, one of the five […]
Baltimore, MD and Liege, Belgium – BD Diagnostics, a segment of global medical technology company BD (Becton, Dickinson and Company), and Diagenode SA, an international biotech company based in Belgium, announced today the European-only launch of the Diagenode Bordetella pertussis/parapertussis real-time polymerase chain reaction (PCR) kit for use on the BD MAX™ System. The Diagenode […]
Gaithersburg, Maryland and SEOUL, Korea, – Seegene Inc., (096530.KQ), a leading developer of multiplex molecular diagnostic technologies and tests, today announced it wouldbe unveiling its multiple mutation detectiontechnology to accelerate the development of companion diagnostic (CDx)tests at the 2013 American Association of Clinical Chemistry (AACC) annual meeting, held in Houston, from July 30 – August […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
